On the basis of lanthanide metalloligands, [Ln(ODA)3]3– (H2ODA = oxydiacetic acid), three series of d–f heterometallic metal–organic frameworks, {[Co(H2O)6]·[Ln2(ODA)6Co2]·6H2O}n [1; Ln = Gd (1a), Dy (1b), and Er (1c)], {[Ln2(ODA)6Cd3(H2O)6]·mH2O}n [2; Ln = Pr (2a), Nd (2b), Sm (2c), Eu (2d), and Dy (2e), m = 9, 6, or 3], and {[Cd(H2O)6]·[Ln2(ODA)6Cd2]·mH2O}n [3; Ln = Dy (3a), Ho (3b), Er (3c), Tm (3d), and Lu (3e), m = 6 or 12], were designed and synthesized by a solvent volatilization and hydrothermal method. Magnetic investigation of 1 reveals the ferromagnetic interactions between the metal ions. In 2, LnIII ions occupied the inversion centers, which are confirmed by the fact that the emission intensity ratio of 5D0 → 7F1 to 5D0 → 7F2 of the EuIII ion is much more than 3 in 2d. It is worth noting that, in 2d, the intensity ratio I(5D0→7F1)/I(5D0→7F2) could decrease significantly upon the introduction of different hydrophilic guest molecules, which implies that the luminescent properties of 2d have a strong dependence on the geometry of the first coordination sphere of the EuIII ion.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: